- Home
- RPRX vs AVY Comparison
RPRX vs AVY Comparison
Compare RPRX & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- AVY
- Stock Information
- Founded
- RPRX 1996
- AVY 1935
- Country
- RPRX United States
- AVY United States
- Employees
- RPRX N/A
- AVY N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- AVY Containers/Packaging
- Sector
- RPRX Health Care
- AVY Consumer Discretionary
- Exchange
- RPRX Nasdaq
- AVY Nasdaq
- Market Cap
- RPRX 14.0B
- AVY 15.4B
- IPO Year
- RPRX 2020
- AVY N/A
- Fundamental
- Price
- RPRX $33.88
- AVY $185.96
- Analyst Decision
- RPRX Strong Buy
- AVY Buy
- Analyst Count
- RPRX 5
- AVY 11
- Target Price
- RPRX $41.60
- AVY $227.15
- AVG Volume (30 Days)
- RPRX 4.6M
- AVY 827.2K
- Earning Date
- RPRX 02-11-2025
- AVY 01-30-2025
- Dividend Yield
- RPRX 2.60%
- AVY 1.91%
- EPS Growth
- RPRX N/A
- AVY 40.81
- EPS
- RPRX 1.91
- AVY 8.73
- Revenue
- RPRX $2,263,576,000.00
- AVY $8,755,700,000.00
- Revenue This Year
- RPRX $29.18
- AVY $3.16
- Revenue Next Year
- RPRX $9.99
- AVY $4.34
- P/E Ratio
- RPRX $17.69
- AVY $21.14
- Revenue Growth
- RPRX N/A
- AVY 4.68
- 52 Week Low
- RPRX $24.05
- AVY $178.72
- 52 Week High
- RPRX $34.16
- AVY $233.48
- Technical
- Relative Strength Index (RSI)
- RPRX 80.55
- AVY 51.06
- Support Level
- RPRX $32.28
- AVY $180.43
- Resistance Level
- RPRX $34.20
- AVY $184.82
- Average True Range (ATR)
- RPRX 0.71
- AVY 3.00
- MACD
- RPRX 0.02
- AVY 0.66
- Stochastic Oscillator
- RPRX 89.40
- AVY 94.64
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.